---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006815"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:38:20.206926+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Provectus Biopharmaceuticals to host conference call on Feb 22, 2024 for company updates

## Summary
- Conference call scheduled for February 22, 2024 at 3:00 p.m. EST to discuss company updates.
- Dial-in: 1-800-319-4610 (US) or 1-604-638-5340 (international); advance registration available.
- No financial results or specific material events disclosed in the press release.

## SEC filing metadata
- accession: 0001493152-24-006815
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315224006815/0001493152-24-006815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315224006815/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006815
- JSON: https://secwatch.observer/filing/0001493152-24-006815.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.